
ICON Public Limited Company ICLR
€ 94.43
3.33%
Geschäftsbericht 2024
hinzugefügt 04.04.2026
ICON Public Limited Company Operativer Cashflow 2011-2026 | ICLR
Operativer Cashflow Jährlich ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.29 B | 1.16 B | 563 M | 829 M | 568 M | 413 M | 269 M | 383 M | 259 M | 279 M | 170 M | 221 M | 113 M | 20.2 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.29 B | 20.2 M | 467 M |
Operativer Cashflow Vierteljährlich ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 227 M | - | - | - | 112 M | - | - | - | 143 M | - | - | - | 94.6 M | - | - | - | 40.5 M | - | - | - | 159 M | - | - | - | - | - | - | - | 61.1 M | - | - | - | 38.7 M | - | - | - | 69.4 M | - | - | - | 60.6 M | - | - | - | -5.28 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 227 M | -5.28 M | 91 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 117.5 | 2.1 % | $ 35.7 B | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 16.83 | 4.86 % | $ 897 M | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 1.45 | 5.84 % | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 23.53 | 1.73 % | $ 654 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 178.34 | 1.53 % | $ 8.84 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.59 | 5.52 % | $ 425 M | ||
|
Medpace Holdings
MEDP
|
713 M | $ 501.23 | 1.56 % | $ 14.5 B | ||
|
NeoGenomics
NEO
|
5.23 M | $ 8.0 | 4.03 % | $ 1.02 B | ||
|
Danaher Corporation
DHR
|
6.42 B | $ 195.87 | 3.3 % | $ 140 B | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
837 M | $ 126.96 | 4.99 % | $ 20.2 B | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 15.3 | 6.03 % | $ 463 M | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 6.72 | 0.6 % | $ 280 M | ||
|
Guardant Health
GH
|
-185 M | $ 82.21 | 4.59 % | $ 10.3 B | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.85 | 5.95 % | $ 92.5 K | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.08 | -2.8 % | $ 4.78 M | ||
|
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.64 | 0.02 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 264.18 | 1.25 % | $ 22 B | ||
|
Natera
NTRA
|
-432 M | $ 201.9 | 4.6 % | $ 19.9 B | ||
|
Celcuity
CELC
|
-153 M | $ 120.4 | 2.78 % | $ 5.63 B | ||
|
Neuronetics
STIM
|
-20.4 M | $ 1.39 | 2.96 % | $ 91.7 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 81.67 | 1.34 % | $ 5.51 B | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 192.91 | 0.73 % | $ 21.4 B | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.14 | -2.97 % | $ 1.98 B | ||
|
ENDRA Life Sciences
NDRA
|
-5.18 M | $ 5.19 | 5.06 % | $ 4.08 M | ||
|
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M |